Alzheimer’s Disease Therapeutics Market Value to Reach USD 30.8 Billion by 2033 | Driven by the Advancements in Neurological Research New York, Jan. 30, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the global Alzheimer’s Disease Therapeutics Market size is forecasted to exceed USD 30.8 Billion by 2033, with a promising CAGR of...

Vielight Commences Pivotal Clinical Trial for Alzheimer’s Disease based on Transcranial Photobiomodulation. Toronto, Canada, June 04, 2019 (GLOBE NEWSWIRE) -- Vielight Inc. of Toronto, a leader in brain photobiomodulation (PBM) technology, announces that the primary site for its pivotal clinical trial,...

9 impressive research efforts underway in Wisconsin Mequon, Jan. 10, 2019 (GLOBE NEWSWIRE) -- With China’s historic moon landing last week and the 50th anniversary of Apollo 11 approaching this summer, 2019 is shaping up to be an exciting year for...